Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 22, 2022

BUY
$2.9 - $5.88 $1,450 - $2,940
500 New
500 $1,000
Q2 2022

Aug 19, 2022

BUY
$5.01 - $14.12 $0 - $0
0 New
0 $0
Q1 2022

May 11, 2022

SELL
$9.41 - $19.3 $3,764 - $7,720
-400 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$18.41 - $29.58 $7,364 - $11,832
400 New
400 $9,000

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $98.4M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.